Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Biopharmaceutics and Pharmacokinetics: Overview

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...

Bioequivalence: Overview

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...

Factors Influencing Bioavailability: First-Pass Elimination

Factors Influencing Bioavailability: First-Pass Elimination

When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Health of Nations Fund: Financing global drug development.

PLOS global public health·2026

Same author

Comparative toxicity of nickel titanate and calcium manganite perovskite nanomaterials in human and bacterial systems: Implications for environmental and health risks.

Chemosphere·2026

Same author

Chronic Inflammation (A Silent Killer) - Molecular Mechanisms and Emerging Therapeutic Approaches.

Current drug targets·2026

Same author

SWOT Analysis on the Perception of Indian Medical Graduate Toward the Family Adoption Program.

Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine·2026

Same author

Pertussis Presenting as New-Onset Uncontrolled Asthma in Children: A Series of Three Cases.

The American journal of tropical medicine and hygiene·2026

Same author

Inhibition of Aβ(40) peptide aggregation by Milk-derived Amyloid-like Protein Aggregates (MAPA).

Biological chemistry·2026

Search research articles

Related Experiment Video

Updated: Jul 4, 2025

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

How does news affect biopharma stock prices?: An event study.

Joonhyuk Cho^1,2,3, Manish Singh^1,2,3, Andrew W Lo^1,3,4,5,6

¹Laboratory for Financial Engineering, MIT, Cambridge, MA, United States of America.

|January 26, 2024

Summary

This summary is machine-generated.

Biopharmaceutical stock prices react significantly to news, with acquisitions boosting returns and setbacks causing losses. Larger companies show less volatile stock price reactions to biopharma news.

More Related Videos

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

Real-time Cytotoxicity Assays in Human Whole Blood

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

Related Experiment Videos

Last Updated: Jul 4, 2025

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

Real-time Cytotoxicity Assays in Human Whole Blood

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

Area of Science:

Finance
Biopharmaceutical Industry Analysis
Event Studies

Background:

The biopharmaceutical sector is highly sensitive to information, impacting stock valuations.
Understanding the relationship between news events and stock price movements is crucial for investors and companies.
Distinguishing between pharmaceutical and biotechnology firms is essential due to differing market dynamics.

Purpose of the Study:

To investigate the impact of various news types on biopharmaceutical stock prices.
To differentiate the effects of news on pharmaceutical versus biotechnology companies.
To analyze the relationship between market capitalization and stock price volatility in response to events.

Main Methods:

Conducted an event study analyzing 503,107 news releases from 1,012 biopharmaceutical companies.
Applied three asset pricing models to estimate abnormal returns.
Regressed abnormal returns on market capitalization and sub-industry indicators.

Main Results:

Acquisition-related news generated the highest positive returns; drug development setbacks led to significant negative returns.
Biotechnology companies exhibited larger means and standard deviations in abnormal returns compared to pharmaceutical companies.
Larger biopharmaceutical companies generally experienced lower magnitudes of abnormal returns in response to events.
News concerning acquisitions and clinical trials were identified as potential sources of information leakage.

Conclusions:

News significantly influences biopharmaceutical stock prices, with varying impacts based on news type and company size.
Biotechnology firms display more volatile stock performance in reaction to news than pharmaceutical firms.
The findings offer valuable insights for stakeholders in the biopharmaceutical sector for informed decision-making.